Seer Q3 revenue falls, cuts 2026 outlook
SEER•Seer reported Q3 revenue of $3.98 million and a net loss of $13.74 million, which narrowed year over year. It lowered its 2026 revenue outlook to $13.5 million-$14.5 million from $16 million-$18 million, citing extended sales cycles amid funding pressure.
1. Quarterly results
Seer’s Q3 revenue fell year over year to $3.98 million. Its net loss narrowed to $13.74 million, operating expenses declined 23% to $16.55 million, and gross margin was 47%.
2. Lowered outlook
The company cut its 2026 revenue guidance to $13.5 million-$14.5 million from $16 million-$18 million. Seer cited pressure on academic and government funding that is extending sales cycles and delaying late-stage opportunities. It said established customers made repeat consumables purchases and new pharmaceutical customers adopted its platform.
